Gene Query: IDH1

Dataset Description Geneva Score
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 128.43
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 103.78
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 95.01
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 76.1
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 63.94
RNA-seq of human fibroblasts after irradiation 52.82
Chromatin-informed inference of transcriptional programs in gynecologic cancers 52.0
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 52.0
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 49.14
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 49.14
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 48.98
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 48.98
H1609088 Human RNA-Sequencing 47.16
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 43.88
Gene expression changes after LOC550643 silencing 43.03
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 41.42
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 41.19
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 40.68
A sister of NANOG regulates genes expressed in pre-implantation human development 39.59
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 39.37
CD73 knockdown effect in pancreatic cancer cell lines 39.25
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 39.18
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 38.86
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 38.51
Transcriptome analysis of SKI knock-out in HL60 cells 38.51
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 37.46
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 37.03
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 36.89
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 35.59
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 34.37
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 33.82
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 33.44
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 33.43
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 32.78
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 32.77
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 32.33
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 31.65
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 31.65
IDH3a KO RNA-seq 31.56
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 31.25
An RNA-centric dissection of host complexes controlling flavivirus infection 31.06
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 31.06
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 30.88
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 30.68
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 30.58
RNA-seq in transgenic cells 30.4
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 30.31
Sensing self and nonself circular RNAs 30.11
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 30.09
Silencing SPIB in attached and floating state of H1703 lung cancer cells 28.84
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 28.81
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 28.78
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 28.61
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 28.59
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 28.22
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 28.22
Downregulation of DDX5/DDX17 and REST 28.21
Knockdown of ADNP in HCT116 colon cancer cells 28.08
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 27.99
Lipid degradation promotes prostate cancer cell survival 27.59
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 27.52
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 27.1
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 26.98
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 26.7
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 26.7
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 26.47
Real-time observation of light-controlled transcription in living cells 25.96
A Unique Epigenomic Landscape Defines Human Erythropoiesis 25.8
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 25.8
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 25.79
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 25.73
Identification of Sin3B regulated genes during quiescence 25.63
ZIKV infection of monocytes activates inflammasome pathways 25.34
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 25.31
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 24.89
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 24.85
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 24.76
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 24.6
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 24.57
DJ-1 is dispensable for human stem cell homeostasis 24.45
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 24.4
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 24.21
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 24.19
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 24.05
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 23.93
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 23.68
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 23.68
Gene expression profiling of leukemia cells following asparagine depletion 23.52
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 23.35
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 22.84
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 22.83
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 22.78
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 22.73
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 22.61
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 22.4
Co-transcriptional loading of RNA export factors shapes the human transcriptome 22.3
RNAseq of HEK293 cells after Chtop knockdown 22.3
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 22.24
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 22.21
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 22.21
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 21.95
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 21.84
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 21.72
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 21.62
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 21.29
Global analyses of the effect of different cellular contexts on microRNA targeting 21.17
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 21.17
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 21.11
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 20.73
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 20.61
METTL3 promotes translation in human cancer cells 20.38
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 20.31
MEIS1 regulates hematopoiesis in hPSCs 20.28
Targeting MTHFD2 in Acute Myeloid Leukemia 20.23
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 20.15
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 20.15
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 20.1
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 20.08
Functional role of SLIT2 and ROBO1 in trophoblasts 19.95
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 19.93
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 19.93
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 19.89
MYCi361 regulates MYC target genes 19.64
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 19.59
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 19.55
Primary human trophoblast from term placenta 19.52
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 19.32
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 19.31
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 19.29
Global expression profiles in cardiac progenitor cells generated by ISX-9 19.29
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 19.05
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 19.05
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 19.03
Differentially expressed vascular development genes for iPSC-ECs from CDI 18.98
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 18.59
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 18.59
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 18.51
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 18.46
NR2F2 study 18.46
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 18.46
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 18.28
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 18.19
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 18.17
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 18.15
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 18.06
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 17.9
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 17.9
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 17.9
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 17.9
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 17.89
Tyrosine Kinase Inhibitor Cardiotoxicity 17.89
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 17.69
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 17.64
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 17.64
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 17.63
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 17.62
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 17.58
RNA-seq analysis to identify the genes regulated by p53-SET interplay 17.34
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 17.3
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 17.29
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 17.16
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 17.09
Differential Gene Expression between MCF10A and MCF7 cells 17.08
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 17.07
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 16.91
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 16.75
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 16.75
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 16.75
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 16.71
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 16.7
RNA-seq differential expression studies: more sequence, or more replication? 16.68
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 16.63
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 16.63
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 16.41
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 16.41
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 16.24
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 16.06
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 16.01
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 15.96
Transcriptomic analysis of LSD1 15.96
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 15.94
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 15.94
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 15.81
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 15.81
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 15.81
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 15.68
Targeting EZH2 in MYCN-amplified Neuroblastoma 15.68
STRIPAK directs PP2A activity to promote oncogenic transformation 15.61
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 15.59
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 15.54
RNA-seq analysis of BAP1-depleted uveal melanoma cells 15.52
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 15.51
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 15.43
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 15.38
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 15.26
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 15.24
NHLRC1 re-expression in cancer cells 15.23
Mitochondrial dsRNA triggers antiviral signalling in humans 15.23
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 15.15
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 15.07
Effect of PRDM11 depletion in U2932 cells 15.03
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 15.0
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 15.0
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 14.99
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 14.99
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 14.98
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 14.78
Statins modulate endothelial transcriptional profile by inhibiting EZH2 14.73
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 14.59
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 14.58
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 14.58
Effect of Influenza virus infection on lncRNA expression in A549 cells 14.56
RNA-seq analyses of human prostate cancer cells 14.52
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 14.49
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 14.4
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 14.4
Changes in human endometrial gland transcriptome over the window of implantation 14.39
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 14.37
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 14.15
NRDE2 negatively regulates nuclear exosome functions 14.14
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 14.09
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 14.07
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 14.06
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 14.02
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 13.99
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 13.82
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 13.67
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 13.66
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 13.65
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 13.64
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 13.59
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 13.56
The comparison of high-throughput single-cell RNA-seq methods 13.53
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 13.43
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 13.41
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 13.41
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 13.41
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 13.41
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 13.4
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 13.39
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 13.32
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 13.32
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 13.32
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 13.26
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 13.2
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 13.2
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 13.19
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 13.15
Crizotinib v. DMSO in SW480 cells 13.13
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 13.11
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 13.08
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 13.06
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 13.03
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 12.98
RNA-seq analysis of control and Myc-induced U2OS cells 12.94
Regulation of Lipids is Central to Replicative Senescence 12.94
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 12.88
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 12.81
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 12.76
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 12.71
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 12.61
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 12.59
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 12.58
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 12.55
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 12.49
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 12.43
In situ CAPTURE of chromatin interactions by biotinylated dCas9 12.43
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 12.41
Gene expression changes upon drug withdrawal (Mel888 cell line) 12.29
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 12.28
EWS-Fli and LNC regulated genes in comparison to GFP samples 12.27
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 12.26
Direct Isolation and Characterization of Human Nephron Progenitors. 12.15
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 12.13
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 12.12
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 12.12
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 12.11
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 12.06
In vitro modeling of human germ cell development using pluripotent stem cells 11.98
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 11.96
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 11.9
Transcriptional profile in human S. haematobium infection 11.88
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 11.87
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 11.84
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 11.7
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 11.67
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 11.67
hnRNP C is a key regulator of protein synthesis in mitosis 11.67
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 11.61
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 11.61
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 11.55
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 11.49
RNA-seq of YB5 cells treated with Proscillaridin A 11.47
Gene expression profile of human iPSC-derived nephron progenitor cells 11.43
Reassessment of Exosome Composition 11.38
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 11.31
RNA-seq of stable and unstable section of human atherosclerotic plaques 11.31
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 11.28
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 11.13
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 11.02
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 10.94
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 10.92
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 10.9
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 10.84
Searching for target genes of miR-508/509/506/514 in HCT116 cells 10.82
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 10.77
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 10.76
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 10.74
Next generation sequencing of small RNAs isolated from exosomes in human semen 10.73
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 10.72
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 10.62
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 10.62
Gene expression alterations of pancreatic intraepithlial neoplasia 10.47
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 10.41
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 10.41
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 10.33
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 10.29
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 10.24
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 10.12
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 10.08
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 10.08
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 10.08
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 10.02
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 10.01
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 9.88
Transcriptomes of oxLDL exposed trained monocytes 9.88
oxLDL exposed trained monocytes 9.88
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 9.85
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 9.85
RNAseq of cell lines with knocked in ESR1 mutations 9.76
Differential responses of human fetal brain neural stem cells to Zika virus infection 9.73
scRNASeq analysis of cycling cardiomyocytes 9.71
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 9.63
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 9.62
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 9.51
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 9.41
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 9.29
Cell responses to dysregulated VZV-induced cell-cell fusion 9.21
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 9.16
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 9.16
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 9.16
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 8.96
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 8.96
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 8.93
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 8.92
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 8.9
Aneuploidy-induced cellular stresses limit autophagic degradation. 8.84
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 8.84
Transcriptome analysis in Neobractatin treated cells 8.82
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 8.78
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 8.73
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 8.73
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 8.64
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 8.63
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 8.58
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 8.54
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 8.51
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 8.44
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 8.26
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 8.26
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 8.2
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 8.11
RNA Seq of HMVEC under hypoxia 8.08
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 8.08
p53 activity results in DNA replication fork processivity 8.02
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 7.95
Trascriptome of thyroid cancer-induced macrophages 7.84
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 7.83
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 7.8
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 7.53
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 7.36
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 7.21
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 7.2
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 7.11
p63 controls the enhancer landscape during keratinocyte differentiation 7.1
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 7.09
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 7.01
Human cells contain natural double-stranded RNAs with potential regulatory capacity 6.92
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 6.86
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 6.67
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 6.52
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 6.52
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 6.42
Transcriptome of human white and brown adipose tissue biopsies 6.39
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 6.36
Leucegene: AML sequencing (part 6) 6.36
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 6.13
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 6.13
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 6.03
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 6.03
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 6.02
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 5.99
Loss of endometrial plasticity in recurrent pregnancy loss 5.99
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 5.73
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 5.7
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 5.59
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 5.59
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 5.55
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 5.55
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 5.5
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 5.5
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 5.42
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 5.38
Effect of BMP inhibition or stimulation of primary human keratinocytes 5.38
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 5.36
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 5.15
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 5.14
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 5.08
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 4.97
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 4.97
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 4.81
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 4.8
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 4.64
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 4.63
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 4.63
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 4.4
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 4.36
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 4.28
Human ovarian granulosa cell transcriptome 4.23
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 4.18
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 4.01
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.93
N6-methyladenine DNA Modification in Glioblastoma 3.93
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 3.66
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 3.55
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 3.53
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 3.49
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 3.38
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 3.24
Gene expression profile of human placenta from T. Cruzi infected mothers 3.2
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 3.18
Measure transcript integrity using RNA-seq data 3.17
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 3.17
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.98
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 2.87
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 2.83
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 2.82
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.77
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 2.76
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 2.69
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 2.58
RNA expression analysis upon JMJD1C depletion 2.53
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 2.53
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 2.51
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 2.5
Effects of transcription on genome - nuclear lamina interactions 2.5
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 2.5
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 2.49
6mer seed toxicity in viral microRNAs 2.46
Gene expression regulated by CSA and CSB in neuroblastoma cell line 2.45
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 2.37
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 2.37
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 2.36
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 2.3
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 2.28
Loss of CREBBP results in gene expression repression in lymphoma cells 2.28
Transcriptome analysis reveals differential splicing events in IPF lung tissue 2.24
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 2.22
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 2.06
Transcriptomes of human monocytes after ex vivo exposure to uric acid 1.91
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 1.87
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.78
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 1.74
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 1.74
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.71
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 1.71
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.59
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 1.57
RNA seq_PDX2_SHP099 1.56
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 1.44
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 1.41
CDK12 mediated transcriptional regulation in U2OS cells 1.4
DAOY-Notch1/Notch2 knockout: transcriptome comparison 1.4
Widespread regulated alternative splicing of single codons accelerates proteome evolution 1.34
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 1.25
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 1.2
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.18
High-resolution comparative analysis of great ape genomes 1.18
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 1.17
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.14
RNA-seq analysis of breast cancer 1.11
RNA-seq analysis and shRNA screen of breast cancer 1.11
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.09
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.09
Solid phase chemistry to covalently and reversibly capture thiolated RNA 0.86
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.83
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.76
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 0.69
Preclinical model of obesity and ER-positive breast cancer 0.6
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.53
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 0.52
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.51
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.49
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.35
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 0.34
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.19
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.15
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.07
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.07
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.06


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation